Literature DB >> 3605662

Ultrastructure of human fetal mammary gland.

P Kellokumpu-Lehtinen, R M Johansson, L J Pelliniemi.   

Abstract

Early cytodifferentiation of human fetal mammary gland was studied at the time of the beginning of the sexual differentiation during the sixth to eleventh developmental weeks. The gland appeared as a solid epithelial ingrowth into the underlying mesenchyme on both sides of the thoracic wall at the age of 5 weeks in both sexes. These ingrowths contained primitive glycogen-rich cells with large nuclei. The surrounding mesenchymal cells gathered around the basal lamina. These cells differentiated into fibroblasts, and collagen fibers were seen in the mesenchyme near the mammary buds. No lumina appeared within the buds during this study. Differences between the male and female mammary epithelium or mesenchyme were not observed, although androgen synthesis and secretion in the fetal testis had already begun. The close connections and concomitant differentiation of the mammary bud epithelium and mesenchyme during the early embryogenesis in this study suggest that epithelio-mesenchymal interaction plays an important role in the differentiation of human mammary gland.

Entities:  

Mesh:

Year:  1987        PMID: 3605662     DOI: 10.1002/ar.1092180111

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  3 in total

Review 1.  Human breast development.

Authors:  B A Howard; B A Gusterson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-04       Impact factor: 2.673

2.  Septic disruption of lactiferous ducts with heterogeneous carcinoma of the breast in a lactating woman.

Authors:  Mohammed Naim; Vanesa T John; Kavita Gaur; Afzal Anees
Journal:  BMJ Case Rep       Date:  2010-08-06

3.  Human breast cancer cells educate macrophages toward the M2 activation status.

Authors:  Sofia Sousa; Régis Brion; Minnamaija Lintunen; Pauliina Kronqvist; Jouko Sandholm; Jukka Mönkkönen; Pirkko-Liisa Kellokumpu-Lehtinen; Susanna Lauttia; Olli Tynninen; Heikki Joensuu; Dominique Heymann; Jorma A Määttä
Journal:  Breast Cancer Res       Date:  2015-08-05       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.